• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性 COVID-19 患者中针对 SARS-CoV-2 的抗原特异性适应性免疫反应,及其与年龄和疾病严重程度的关联。

Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity.

机构信息

Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA.

Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego (UCSD), La Jolla, CA 92037, USA.

出版信息

Cell. 2020 Nov 12;183(4):996-1012.e19. doi: 10.1016/j.cell.2020.09.038. Epub 2020 Sep 16.

DOI:10.1016/j.cell.2020.09.038
PMID:33010815
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7494270/
Abstract

Limited knowledge is available on the relationship between antigen-specific immune responses and COVID-19 disease severity. We completed a combined examination of all three branches of adaptive immunity at the level of SARS-CoV-2-specific CD4 and CD8 T cell and neutralizing antibody responses in acute and convalescent subjects. SARS-CoV-2-specific CD4 and CD8 T cells were each associated with milder disease. Coordinated SARS-CoV-2-specific adaptive immune responses were associated with milder disease, suggesting roles for both CD4 and CD8 T cells in protective immunity in COVID-19. Notably, coordination of SARS-CoV-2 antigen-specific responses was disrupted in individuals ≥ 65 years old. Scarcity of naive T cells was also associated with aging and poor disease outcomes. A parsimonious explanation is that coordinated CD4 T cell, CD8 T cell, and antibody responses are protective, but uncoordinated responses frequently fail to control disease, with a connection between aging and impaired adaptive immune responses to SARS-CoV-2.

摘要

关于抗原特异性免疫反应与 COVID-19 疾病严重程度之间的关系,目前所知有限。我们在急性和恢复期患者中完成了对适应性免疫三个分支的综合检查,包括 SARS-CoV-2 特异性 CD4 和 CD8 T 细胞以及中和抗体反应。SARS-CoV-2 特异性 CD4 和 CD8 T 细胞均与疾病较轻相关。协调的 SARS-CoV-2 特异性适应性免疫反应与疾病较轻相关,表明 CD4 和 CD8 T 细胞在 COVID-19 的保护性免疫中均发挥作用。值得注意的是,≥65 岁的个体中 SARS-CoV-2 抗原特异性反应的协调性被破坏。幼稚 T 细胞的缺乏也与衰老和不良疾病结局相关。一个简单的解释是,协调的 CD4 T 细胞、CD8 T 细胞和抗体反应具有保护作用,但不协调的反应常常无法控制疾病,衰老与 SARS-CoV-2 的适应性免疫反应受损之间存在联系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcf/7664837/2d5314d1e556/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcf/7664837/5416a3b85844/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcf/7664837/9e7ad8e2e7ee/figs1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcf/7664837/4138243f96ac/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcf/7664837/f7309201a613/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcf/7664837/a5c011c9551b/figs2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcf/7664837/b632662b672e/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcf/7664837/ffc311575b24/figs3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcf/7664837/3930e7249934/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcf/7664837/4010e825a9cc/figs4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcf/7664837/c45d369395c9/figs5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcf/7664837/e5ce913dc1cd/figs6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcf/7664837/7541d4d88140/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcf/7664837/75d14fe19c67/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcf/7664837/e5b630ed1bef/figs7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcf/7664837/2d5314d1e556/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcf/7664837/5416a3b85844/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcf/7664837/9e7ad8e2e7ee/figs1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcf/7664837/4138243f96ac/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcf/7664837/f7309201a613/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcf/7664837/a5c011c9551b/figs2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcf/7664837/b632662b672e/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcf/7664837/ffc311575b24/figs3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcf/7664837/3930e7249934/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcf/7664837/4010e825a9cc/figs4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcf/7664837/c45d369395c9/figs5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcf/7664837/e5ce913dc1cd/figs6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcf/7664837/7541d4d88140/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcf/7664837/75d14fe19c67/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcf/7664837/e5b630ed1bef/figs7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcf/7664837/2d5314d1e556/gr7.jpg

相似文献

1
Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity.急性 COVID-19 患者中针对 SARS-CoV-2 的抗原特异性适应性免疫反应,及其与年龄和疾病严重程度的关联。
Cell. 2020 Nov 12;183(4):996-1012.e19. doi: 10.1016/j.cell.2020.09.038. Epub 2020 Sep 16.
2
Broad and strong memory CD4 and CD8 T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19.在 COVID-19 之后,英国康复个体中 SARS-CoV-2 诱导产生的广泛而强大的记忆性 CD4 和 CD8 T 细胞。
Nat Immunol. 2020 Nov;21(11):1336-1345. doi: 10.1038/s41590-020-0782-6. Epub 2020 Sep 4.
3
Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses.急性严重急性呼吸综合征冠状病毒 2 感染损害树突状细胞和 T 细胞应答。
Immunity. 2020 Oct 13;53(4):864-877.e5. doi: 10.1016/j.immuni.2020.07.026. Epub 2020 Aug 4.
4
SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection.SARS-CoV-2 T 细胞免疫:特异性、功能、持久性及其在保护中的作用。
Sci Immunol. 2020 Jul 17;5(49). doi: 10.1126/sciimmunol.abd6160.
5
Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals.严重与轻度个体对 SARS-CoV-2 感染的适应性免疫反应。
Signal Transduct Target Ther. 2020 Aug 14;5(1):156. doi: 10.1038/s41392-020-00263-y.
6
Suboptimal SARS-CoV-2-specific CD8 T cell response associated with the prominent HLA-A*02:01 phenotype.与 HLA-A*02:01 表型显著相关的 SARS-CoV-2 特异性 CD8 T 细胞反应不佳。
Proc Natl Acad Sci U S A. 2020 Sep 29;117(39):24384-24391. doi: 10.1073/pnas.2015486117. Epub 2020 Sep 10.
7
Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome.急性呼吸窘迫综合征的 COVID-19 患者中 SARS-CoV-2 特异性 T 细胞的表型和动力学。
Sci Immunol. 2020 Jun 26;5(48). doi: 10.1126/sciimmunol.abd2071.
8
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals.COVID-19 疾病患者和未接触者体内针对 SARS-CoV-2 冠状病毒的 T 细胞反应的靶标。
Cell. 2020 Jun 25;181(7):1489-1501.e15. doi: 10.1016/j.cell.2020.05.015. Epub 2020 May 20.
9
Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response.免疫反应随衰老而重塑:免疫衰老及其对 COVID-19 免疫反应的潜在影响。
Front Immunol. 2020 Aug 7;11:1748. doi: 10.3389/fimmu.2020.01748. eCollection 2020.
10
SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay.采用 ex vivo ELISpot assay 检测 COVID-19 恢复期患者和未接触者的 SARS-CoV-2 特异性 T 细胞免疫。
Clin Microbiol Infect. 2021 Jul;27(7):1029-1034. doi: 10.1016/j.cmi.2021.03.010. Epub 2021 Apr 2.

引用本文的文献

1
Bivalent mRNA booster encoding virus-like particles elicits potent polyclass RBD antibodies in pre-vaccinated mice.编码病毒样颗粒的二价mRNA加强针在预先接种疫苗的小鼠中引发强效多类RBD抗体。
bioRxiv. 2025 Aug 19:2025.08.18.670983. doi: 10.1101/2025.08.18.670983.
2
A Multi-Antigen Broad-Spectrum Coronavirus Vaccine Induces Potent and Durable Cross-Protection Against Infection and Disease Caused by Multiple SARS-CoV-2 Variants.一种多抗原广谱冠状病毒疫苗可诱导针对多种新冠病毒变异株引起的感染和疾病产生强效且持久的交叉保护。
Res Sq. 2025 Aug 20:rs.3.rs-7208748. doi: 10.21203/rs.3.rs-7208748/v1.
3
Molecular basis of potent antiviral HLA-C-restricted CD8 T cell response to an immunodominant SARS-CoV-2 nucleocapsid epitope.

本文引用的文献

1
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months.针对 SARS-CoV-2 感染的强大中和抗体可长期存在。
Science. 2020 Dec 4;370(6521):1227-1230. doi: 10.1126/science.abd7728. Epub 2020 Oct 28.
2
Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4 T Cells in COVID-19.COVID-19 中 SARS-CoV-2 反应性调节性和细胞毒性 CD4 T 细胞的失衡。
Cell. 2020 Nov 25;183(5):1340-1353.e16. doi: 10.1016/j.cell.2020.10.001. Epub 2020 Oct 5.
3
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19.
针对免疫显性的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)核衣壳表位的高效抗病毒HLA-C限制性CD8 T细胞应答的分子基础
Nat Commun. 2025 Aug 28;16(1):8062. doi: 10.1038/s41467-025-63288-3.
4
Long-Term Durability and Variant-Specific Modulation of SARS-CoV-2 Humoral and Cellular Immunity over Two Years.两年间 SARS-CoV-2 体液免疫和细胞免疫的长期持久性及变异株特异性调节
Int J Mol Sci. 2025 Aug 21;26(16):8106. doi: 10.3390/ijms26168106.
5
Factors Influencing COVID-19 Viral Clearance: Implications for Vaccination and Antiviral Therapy.影响新冠病毒清除的因素:对疫苗接种和抗病毒治疗的启示
Infect Drug Resist. 2025 Aug 21;18:4227-4240. doi: 10.2147/IDR.S515224. eCollection 2025.
6
SARS-CoV-2 XBB.1.5 infects wild-type C57BL/6 mice and induces a protective CD4 T cell response required for viral clearance.严重急性呼吸综合征冠状病毒2型XBB.1.5感染野生型C57BL/6小鼠,并诱导病毒清除所需的保护性CD4 T细胞反应。
Front Cell Infect Microbiol. 2025 Aug 1;15:1621226. doi: 10.3389/fcimb.2025.1621226. eCollection 2025.
7
Impaired Long-Term Quantitative Cellular Response to SARS-CoV-2 Vaccine in Thiopurine-Treated IBD Patients.硫嘌呤治疗的炎症性肠病患者对SARS-CoV-2疫苗的长期定量细胞反应受损。
Cells. 2025 Jul 26;14(15):1156. doi: 10.3390/cells14151156.
8
Highly conserved Betacoronavirus sequences are broadly recognized by human T cells.高度保守的β冠状病毒序列被人类T细胞广泛识别。
Cell. 2025 Jul 30. doi: 10.1016/j.cell.2025.07.015.
9
Modeling Antibody Kinetics Post-mRNA Booster Vaccination and Protection Durations Against SARS-CoV-2 Infection.mRNA加强疫苗接种后抗体动力学建模及针对SARS-CoV-2感染的保护持续时间
J Med Virol. 2025 Aug;97(8):e70521. doi: 10.1002/jmv.70521.
10
T cell epitope mapping reveals immunodominance of evolutionarily conserved regions within SARS-CoV-2 proteome.T细胞表位图谱分析揭示了严重急性呼吸综合征冠状病毒2(SARS-CoV-2)蛋白质组中进化保守区域的免疫显性。
iScience. 2025 Jul 2;28(8):113044. doi: 10.1016/j.isci.2025.113044. eCollection 2025 Aug 15.
无症状或轻症 COVID-19 康复者体内具有强大的 T 细胞免疫。
Cell. 2020 Oct 1;183(1):158-168.e14. doi: 10.1016/j.cell.2020.08.017. Epub 2020 Aug 14.
4
An inflammatory cytokine signature predicts COVID-19 severity and survival.炎症细胞因子特征可预测 COVID-19 严重程度和存活情况。
Nat Med. 2020 Oct;26(10):1636-1643. doi: 10.1038/s41591-020-1051-9. Epub 2020 Aug 24.
5
Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients.新冠病毒肺炎患者中中和抗体反应的快速产生
Cell Rep Med. 2020 Jun 23;1(3):100040. doi: 10.1016/j.xcrm.2020.100040. Epub 2020 Jun 8.
6
A dynamic COVID-19 immune signature includes associations with poor prognosis.一个动态的 COVID-19 免疫特征包括与预后不良的关联。
Nat Med. 2020 Oct;26(10):1623-1635. doi: 10.1038/s41591-020-1038-6. Epub 2020 Aug 17.
7
Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses.急性严重急性呼吸综合征冠状病毒 2 感染损害树突状细胞和 T 细胞应答。
Immunity. 2020 Oct 13;53(4):864-877.e5. doi: 10.1016/j.immuni.2020.07.026. Epub 2020 Aug 4.
8
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2.开发一种具有强大预防 SARS-CoV-2 能力的灭活疫苗候选物,BBIBP-CorV。
Cell. 2020 Aug 6;182(3):713-721.e9. doi: 10.1016/j.cell.2020.06.008. Epub 2020 Jun 6.
9
Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques.单次接种 Ad26 疫苗可预防恒河猴感染 SARS-CoV-2。
Nature. 2020 Oct;586(7830):583-588. doi: 10.1038/s41586-020-2607-z. Epub 2020 Jul 30.
10
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19.SARS-CoV-2 反应性 T 细胞在健康供体和 COVID-19 患者中的研究。
Nature. 2020 Nov;587(7833):270-274. doi: 10.1038/s41586-020-2598-9. Epub 2020 Jul 29.